Impact of pretransplant rituximab induction on highly sensitized kidney recipients: comparison with non-rituximab group

PURPOSE: Highly sensitized patients with a high level of panel reactive antibody (PRA) experience more episodes of antibody-mediated rejection (AMR) and poorer graft survival than non-sensitized patients. Rituximab is a well-known monoclonal anti-CD20 antibody that causes the depletion of B lymphocy...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Song, Young Hae, Huh, Kyu Ha, Kim, Yu Seun, Lee, Hyung Soon, Kim, Myoung Soo, Kim, Soo Jin, Kim, Hyun Jung, Kim, Soon Il, Joo, Dong Jin
Format: Artigo
Idioma:Inglês
Publicat: The Korean Surgical Society 2012
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3373982/
https://ncbi.nlm.nih.gov/pubmed/22708094
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4174/jkss.2012.82.6.335
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars